Diagnostic and Clinical Significance of KIT(CD117) Expression in Thymic Epithelial Tumors in China |
Song, Nan
(Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine)
Chen, Gang (Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine) Zhang, Peng (Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine) Liu, Ming (Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine) He, Wen-Xin (Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine) Jiang, Ge-Ning (Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine) |
1 | de Jong WK, Blaauwgeers JL, Schaapveld M, et al (2008). Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer, 44, 123-30. DOI ScienceOn |
2 | Edling CE, Hallberg B (2007). c-Kit-a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol, 39, 1995-8. DOI |
3 | Giaccone G, Rajan A, Ruijter R, et al (2009). Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas. J Thorac Oncol, 4, 1270-3. DOI |
4 | Heinrich MC, Rubin BP, Longley BJ, Fletcher JA (2002). Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol, 33, 484-95. DOI ScienceOn |
5 | Masaoka A, Yamakawa Y, Niwa H, et al (1994). Thymectomy and malignancy. Eur J Cardiothorac Surg, 8, 251-3. DOI |
6 | Muller-Hermelink HK, Engel P, Kuo TT, et al (2004). Tumors of the thymus: introduction. In: Travis, WD.; Brambilla, E.; Muller-Hermelink, HK., et al., editors. Pathology and Genetics. Tumors of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumors. Lyon: IARC Press, p146- 247. |
7 | Nakagawa K, Matsuno Y, Kunitoh H, et al (2005). Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest, 128, 140-4. DOI |
8 | Pan CC, Chen PC, Chiang H (2004). Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol, 121, 878-83. DOI |
9 | Petrini I, Zucali PA, Lee HS, et al (2010). Expression and mutational status of c-kit in thymic epithelial tumors. J Thorac Oncol, 5, 1447-53. DOI |
10 | Strobel P, Bargou R, Wolff A, et al (2010). Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer, 103, 196-200. DOI |
11 | Strobel P, Hartmann M, Jakob A, et al (2004). Thymic carcinoma with overexpression of mutated KITand the response to imatinib. N Engl J Med, 350, 2625-6. DOI ScienceOn |
12 | Tsuchida M, Umezu H, Hashimoto T, et al (2008). Absence of gene mutations in KIT-positive thymic epithelial tumors. Lung Cancer, 62, 321-5. DOI |
13 | Vandenbark GR, de Castro CM, Taylor H, et al (1992). Cloning and structural analysis of the human c-kit gene. Oncogene, 7, 1259-66. |
14 | Corless CL, Fletcher JA, Heinrich MC (2004). Biology of gastrointestinal stromal tumors. J Clin Oncol, 22, 3813-25. DOI ScienceOn |
15 | Aisner SC, Dahlberg S, Hameed MR, et al (2010). Epidermal growth factor receptor, C-kit,and Her2/neu immunostaining in advanced or recurrentthymic epithelial neoplasms staged according to the 2004 World Health Organization in patientstreated with octreotide and prednisone: an Eastern Cooperative Oncology Group study. J Thorac Oncol, 5, 885-92. DOI |
16 | Arbiser JL, Govindarajan B, Bai X, et al (2002). Functional tyrosine kinase inhibitor profiling: a generally applicable method points to a novel role of platelet-derived growth factor receptor-beta in tuberous sclerosis. Am J Pathol, 161, 781-6. DOI |